CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

AnazaoHealth Corporation

AnazaoHealth Corporation is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Tampa, FL. To find more information about AnazaoHealth Corporation, please visit www.anazaohealth.com

Integrated Medical Dlvry

Integrated Medical Dlvry LLC is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Instem LSS

Instem LSS is a Conshohocken, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

THE WELL

THE WELL is a modern membership-based wellness club designed for busy urban professionals in the heart of New York City.

Kips Bay Medical

Kips Bay Medical is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.